首页> 外文期刊>African Journal of Pharmacy and Pharmacology >Inhibitory effect of oxymatrine on the proliferation and vascular endothelial growth factor A (VEGF-A) expression in human lung adenocarcinoma (SPC-A-1) cell
【24h】

Inhibitory effect of oxymatrine on the proliferation and vascular endothelial growth factor A (VEGF-A) expression in human lung adenocarcinoma (SPC-A-1) cell

机译:氧化苦参碱对人肺腺癌细胞(SPC-A-1)增殖和血管内皮生长因子A(VEGF-A)表达的抑制作用

获取原文
           

摘要

The aims of this study were to investigate the effect of oxymatrine (OMA) on?human lung adenocarcinoma?(SPC-A-1) as well as to explore the underlying mechanism. The inhibitory effects of OMA on the growth of SPC-A-1 cells were tested by using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method, apoptosis assay and the expressions of vascular endothelial growth factor A (VEGF-A). OMA with different concentrations had significant inhibitory effects on the growth of?SPC-A-1?and could also induce apoptosis. In addition, real time-polymerase chain reaction (RT-PCR) analysis indicated that OMA dramatically reduced the secretion of VEGF dose-dependently. The results suggested that OMA might have the therapeutic application in the treatment of human lung adenocarcinoma cell lung cancer.
机译:本研究的目的是研究氧化苦参碱(OMA)对“人肺腺癌”(SPC-A-1)的作用,并探讨其潜在机制。用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴化物(MTT)法检测OMA对SPC-A-1细胞生长的抑制作用,并检测其凋亡和其表达。血管内皮生长因子A(VEGF-A)。不同浓度的OMA对?SPC-A-1?的生长有明显的抑制作用,并可能诱导细胞凋亡。此外,实时聚合酶链反应(RT-PCR)分析表明,OMA显着降低了VEGF的分泌,呈剂量依赖性。结果提示OMA可能在治疗人肺腺癌细胞肺癌中具有治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号